Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-19T17:36:49.544Z Has data issue: false hasContentIssue false
  • English
  • Français

Developing a Roadmap for Mass Vaccination of COVID-19 in Iran: A Qualitative Study

Published online by Cambridge University Press:  16 November 2022

Hesam Seyedin ,
Mohsen Dowlati Open the ORCID record for Mohsen Dowlati [Opens in a new window] ,
Mohammad Barzegar ,
Saeid Bahramzadeh ,
Abed Khanizade ,
Mostafa Roshanravan ,
Haleh Adibi ,
Fahimeh Barghi-Shirazi Open the ORCID record for Fahimeh Barghi-Shirazi [Opens in a new window]  and
Mahboubeh Rouhollahi
Hesam Seyedin
Affiliation:
Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran Department of Health in Disasters and Emergencies, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
Mohsen Dowlati*
Affiliation:
Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran Department of Health in Disasters and Emergencies, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
Mohammad Barzegar
Affiliation:
Department of Foreign Languages, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
Saeid Bahramzadeh
Affiliation:
Department of Health in Disasters and Emergencies, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
Abed Khanizade
Affiliation:
Department of Health in Disasters and Emergencies, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
Mostafa Roshanravan
Affiliation:
Department of Health in Disasters and Emergencies, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
Haleh Adibi
Affiliation:
Department of Health in Disasters and Emergencies, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
Fahimeh Barghi-Shirazi
Affiliation:
Department of Health in Disasters and Emergencies, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
Mahboubeh Rouhollahi
Affiliation:
Department of Health in Disasters and Emergencies, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
*
Corresponding author: Mohsen Dowlati, Email: dowlati.m@iums.ac.ir.
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Nowadays, the Covid-19 pandemic is 1 of the most important challenges worldwide, especially in terms of health. The most important strategy to prevent and control the Covid-19 pandemic is mass vaccination. This study aimed at developing a roadmap for the mass vaccination of COVID-19 in Iran.

Methods:

The current study was conducted using a qualitative approach with a content analysis method. In the first step, the review of literature and documents was carried out by a search in scientific databases. In the next step, the data were amassed via in-depth and semi-structured interviews with experts who were selected purposefully, including policymakers, health care workers, and managers. After this, 3 multidisciplinary expert panels for roadmap development were held.

Results:

Based on the literature review, interviews, and 3 stages of an expert panel, the final roadmap was developed with 5 dimensions. These included outcomes, planning and preparation, strategies, and preparation, implementation, monitoring, and evaluation.

Conclusions:

This roadmap was developed to improve mass vaccination during the COVID-19 pandemic. According to our findings, it is strongly recommended that the vaccination roadmap with all the above-mentioned features and comprehensive structure should be applied to mitigate the consequences of the COVID-19 pandemic.

Keywords

COVID-19vaccinationroadmapqualitative
Type
Original Research
Information
Disaster Medicine and Public Health Preparedness , Volume 17 , 2023 , e295
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baniasad, M, Mofrad, MG, Bahmanabadi, B, Jamshidi, S. COVID-19 in Asia: Transmission factors, re-opening policies, and vaccination simulation. Environ Res. 2021;202:111657.CrossRefGoogle ScholarPubMed
World Health Organization (WHO). WHO Coronavirus (COVID-19) dashboard 2021 [updated 30 August 2021. Available from: https://covid19.who.int/ Google Scholar
Kumar, VM, Pandi-Perumal, SR, Trakht, I, Thyagarajan, SP. Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases. NPJ Vaccines. 2021;6(1):1-7.CrossRefGoogle ScholarPubMed
Shah, A, Marks, PW, Hahn, SM. Unwavering regulatory safeguards for COVID-19 vaccines. J AMA. 2020;324(10):931-2.Google ScholarPubMed
Raoofi, A, Takian, A, Sari, AA, Olyaeemanesh, A, Haghighi, H, Aarabi, M. COVID-19 pandemic and comparative health policy learning in Iran. Arch Iran Med. 2020;23(4):220-34.CrossRefGoogle ScholarPubMed
WHO. Iran Situation 2021 [updated August 18, 2021]. https://covid19.who.int/region/emro/country/ir Google Scholar
Salimi, R, Gomar, R, Heshmati, B. The COVID-19 outbreak in Iran. J Glob Health. 2020;10(1):1-4.CrossRefGoogle ScholarPubMed
DeRoo, SS, Pudalov, NJ, Fu, LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323(24):2458-9.CrossRefGoogle Scholar
Medaglini, D, De Azero, MR, Leroy, O, Bietrix, F, Denoel, P. Innovation partnership for a roadmap on vaccines in Europe (IPROVE): a vision for the vaccines of tomorrow. Vaccine. 2018;36(9):1136-45.CrossRefGoogle ScholarPubMed
Jain, VK, Iyengar, KP, Ish, P. Elucidating causes of COVID-19 infection and related deaths after vaccination. Diabetes Metab Syndr: Clin Res Rev. 2021;15(5):102212.CrossRefGoogle ScholarPubMed
Hyland, P, Vallières, F, Shevlin, M,. Resistance to COVID-19 vaccination has increased in Ireland and the United Kingdom during the pandemic. Public Health. 2021;195:54-6.CrossRefGoogle ScholarPubMed
Heidari, M, Jafari, H. Challenges of COVID-19 vaccination in Iran: in the fourth wave of pandemic spread. Prehosp Disaster Med. 2021:1-2.Google ScholarPubMed
Kumar, VM, Pandi-Perumal, SR, Trakht, I, Thyagarajan SPJnV. Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases. 2021;6(1):1-7.Google Scholar
Maserat, E, Keikha, L, Davoodi, S, Mohammadzadeh, Z. E-health roadmap for COVID-19 vaccine coverage in Iran. BMC Public Health. 2021;21(1):1-11.CrossRefGoogle ScholarPubMed
Kleine, O, Braun, A. Documentation of the roadmapping methodology and overview over the roadmapping documents. RockEU Robotics Coordination Action for Europe. 2016;Deliverable D1 112014.Google Scholar
Phaal, R. Roadmapping bibliography. 2009. Accessed October 31, 2019. https://www.ifm.eng.cam.ac.uk/uploads/Research/CTM/Roadmapping/Roadmapping_Bibliography_Phaal.pdf.Google Scholar
Lurie, N, Saville, M, Hatchett, R, Halton, JJNEJoM. Developing Covid-19 vaccines at pandemic speed. 2020;382(21):1969-73.Google Scholar
International Chamber of Shipping. Coronavirus (COVID-19) roadmap for vaccination of international seafarers. Version 1.0; 2021.Google Scholar
Arab-Zozani, M, Ghoddoosi-Nejad, DJDM, Preparedness, PH. Covid-19 in Iran: the good, the bad, and the ugly strategies for preparedness–A report from the field. Disaster Med Pubic Health Prep. 2021;15(2):e43-e5.CrossRefGoogle ScholarPubMed
Aiyar, Y, Chandru, V, Chatterjee, M, et al. India’s resurgence of COVID-19: urgent actions needed. Lancet. 2021;397(10291):2232-2234.CrossRefGoogle ScholarPubMed
Park, C-Y, Kim, K, Helble, M, Roth, S. Getting ready for the COVID-19 vaccine rollout. ADB. 2021.CrossRefGoogle Scholar
Strodel, R, Dayton, L, Garrison-Desany, HM, et al. COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: n analysis of state plans. 2021;16(6):e0253208.CrossRefGoogle Scholar
Giubilini, A, Savulescu, J, Wilkinson, D. COVID-19 vaccine: vaccinate the young to protect the old?. J Law Biosci. 2020;7(1):lsaa050. doi: 10.1093/jlb/lsaa050 CrossRefGoogle Scholar
Persad, G, Emanuel, EJ, Sangenito, S, Glickman, A, Phillips, S, Largent, EA. Public perspectives on COVID-19 vaccine prioritization. JAMA Netw Open. 2021;4(4):e217943. doi: 10.1001/jamanetworkopen.2021.7943 CrossRefGoogle ScholarPubMed
Schaffer DeRoo, S, Pudalov, NJ, Fu, LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323(24):2458-2459. doi: 10.1001/jama.2020.8711 CrossRefGoogle ScholarPubMed
Al Awaidy, ST, Khamis, F. Preparing the community for a vaccine against COVID-19. Oman Med J. 2020;35(6):e193. doi: 10.5001/omj.2020.130 Google ScholarPubMed
McMurry, R, Lenehan, P, Awasthi, S, et al. Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines. Med (N Y). 2021;2(8):965-978.e5. doi: 10.1016/j.medj.2021.06.006 Google ScholarPubMed
Xing, K, Tu, XY, Liu, M, et al. Efficacy and safety of COVID-19 vaccines: a systematic review. Zhongguo Dang Dai Er Ke Za Zhi. 2021;23(3):221-228. doi: 10.7499/j.issn.1008-8830.2101133 Google ScholarPubMed
Gee, J, Marquez, P, Su, J, et al. First month of COVID-19 vaccine safety monitoring - United States, December 14, 2020-January 13, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(8):283-288. doi: 10.15585/mmwr.mm7008e3 CrossRefGoogle Scholar
Karafillakis, E, Van Damme, P, Hendrickx, G, Larson, HJ. COVID-19 in Europe: new challenges for addressing vaccine hesitancy. Lancet. 2022;399(10326):699-701. doi: 10.1016/S0140-6736(22)00150-7 CrossRefGoogle ScholarPubMed
Asgary, A, Najafabadi, MM, Karsseboom, R, Wu, J. A Drive-through simulation tool for mass vaccination during COVID-19 pandemic. Healthcare. 2020; 8(4):469. https://doi.org/10.3390/healthcare8040469 CrossRefGoogle ScholarPubMed
Mbindyo, R, Kioko, J, Siyoi, F, et al. Legal and institutional foundations for universal health coverage, Kenya. Bull World Health Organ. 2020;98(10):706-718. doi: 10.2471/BLT.19.237297 CrossRefGoogle ScholarPubMed